Medtronic announces intent to separate Diabetes business
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/2/2026
- Wall Street ends lower as higher yields, rising oil prices mark shaky start to September
- Oil prices jump 4% as fresh US-Iran fighting stokes supply fears
- Two Saudi tankers struck in Strait of Hormuz Monday
- Dell again lifts annual forecasts as AI demand powers record results
- Fed’s Barr backs rate hike if inflation fails to cool, September odds hit 66%
- GoPro to merge with Starman Optical in $285M recapitalization deal
- GoPro (GPRO) Halted, News Pending
- Wall Street ends lower as higher yields, rising oil prices mark shaky start to September
- Gap taps Coach architect Reed Krakoff for $29.95-$498 handbag line
- Comstock Resources signs $1.65B deal with SOCAR, $450M JV
Evercore ISI Removes Medtronic, Inc. (MDT) from TAP List
May 21, 2025 4:52 PM EDTEvercore ISI analyst Vijay Kumar reiterated an Outperform rating and $103.00 price target on Medtronic, Inc. (NYSE: MDT).
The analyst comments "Heading into earnings, we had TAP (tactical, actionable, positioning) calls on A, DHR, ENOV, MDT, SYK, TMO, & RVTY (previous tap note... More
Medtronic, Inc. (MDT) PT Lowered to $98 at Citi
May 21, 2025 2:08 PM EDTCiti analyst Joanna Wuensch lowered the price target on Medtronic, Inc. (NYSE: MDT) to $98.00 (from $103.00) while maintaining a Buy rating.
The analyst comments "This was a quarterly report where many things seemed to go right for Medtronic: 1) FY4Q25 revenue $8.93B (up 5.4% y/y... More
